Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
eqs_en 
0 19.01.24
Unaudited NAV for December 2023
Unaudited NAV for December 2023
Unaudited NAV for December 2023
eqs_en 
0 19.01.24
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
eqs_en 
0 08.01.24
Publication of Circular and RTW Bio Prospectus
Publication of Circular and RTW Bio Prospectus
Publication of Circular and RTW Bio Prospectus
eqs_en 
0 05.01.24
Update regarding timing of Proposed Scheme of Reconstruction
Update regarding timing of Proposed Scheme of Reconstruction
Update regarding timing of Proposed Scheme of Reconstruction
eqs_en 
0 22.12.23
Unaudited NAV for November 2023
Unaudited NAV for November 2023
Unaudited NAV for November 2023
eqs_en 
0 13.12.23
Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial
Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial
Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial
eqs_en 
0 08.12.23
Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
eqs_en 
0 13.11.23
Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
eqs_en 
0 10.11.23
PDMR Notification & Director Shareholding
PDMR Notification & Director Shareholding
PDMR Notification & Director Shareholding
eqs_en 
0 10.11.23
Unaudited NAV for October 2023
Unaudited NAV for October 2023
Unaudited NAV for October 2023
eqs_en 
0 08.11.23
PDMR Notification & Director Shareholding
PDMR Notification & Director Shareholding
PDMR Notification & Director Shareholding
eqs_en 
0 02.11.23
Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
eqs_en 
0 01.11.23
Portfolio company Harpoon Therapeutics announces up to $150 million private placement
Portfolio company Harpoon Therapeutics announces up to $150 million private placement
Portfolio company Harpoon Therapeutics announces up to $150 million private placement
eqs_en 
0 24.10.23
Unaudited NAV for September 2023
Unaudited NAV for September 2023
Unaudited NAV for September 2023
eqs_en 
0 06.10.23
Interim Results for the Six Months Ended 30 June 2023
Interim Results for the Six Months Ended 30 June 2023
Interim Results for the Six Months Ended 30 June 2023
eqs_en 
0 27.09.23
Board Change
Board Change
Board Change
eqs_en 
0 27.09.23
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation
eqs_en 
0 14.09.23
Unaudited NAV for August 2023
Unaudited NAV for August 2023
Unaudited NAV for August 2023
eqs_en 
0 14.09.23
Unaudited NAV for July 2023
Unaudited NAV for July 2023
Unaudited NAV for July 2023
eqs_en 
0 07.08.23
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
eqs_en 
0 17.07.23
Arix Announces Strategic Review
Arix Announces Strategic Review
Arix Announces Strategic Review
eqs_en 
0 13.07.23
Unaudited NAV for June 2023
Unaudited NAV for June 2023
Unaudited NAV for June 2023
eqs_en 
0 13.07.23
Portfolio company Disc Medicine raises $157.8 million in public offering
Portfolio company Disc Medicine raises $157.8 million in public offering
Portfolio company Disc Medicine raises $157.8 million in public offering
eqs_en 
0 23.06.23
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
eqs_en 
0 09.06.23